Press and News Items

support_agent

Your contact persons

CHEPLAPHARM Arzneimittel GmbH

Welcome to our news section. This is where we provide you with first hand news and information from and about CHEPLAPHARM. We offer you a broad range of current information and materials for all publishing needs. All texts and images are free to use for editorial purposes.

Press

Our News

View:
format_list_bulleted grid_view

07/23/2025

Tender Offer Early Results Announcement
Press releases
Read more chevron_right

07/16/2025

CHEPLAPHARM expands collaboration with Boryung (South Korea) in manufacture of Zyprexa® tablets
Press releases
Read more chevron_right

07/09/2025

Tender Offer Launch Release
Press releases
Read more chevron_right

07/02/2025

Satisfaction Notice to Conditional Redemption
Press releases
Read more chevron_right

06/26/2025

High Demand and Attractive Pricing: CHEPLAPHARM's New 7.125% Bond Multiple Times Oversubscribed
Press releases
Read more chevron_right

06/19/2025

Notice on Conditional Full Redemption
Press releases
Read more chevron_right

06/18/2025

CHEPLAPHARM Arzneimittel GmbH Announces Pricing of €750,000,000 7.125% Senior Secured Notes due 2031
Press releases
Read more chevron_right

06/16/2025

CHEPLAPHARM Arzneimittel GmbH Announces Offering of Senior Secured Notes due 2031
Press releases
Read more chevron_right

06/02/2025

Sandra Schröder joins CHEPLAPHARM's management team as VP Scientific
Press releases
Read more chevron_right

Archive

Back to top expand_less